Aptamer-capped nanocrystal quantum dots

Quantum dots, used increasingly as bright fluorescent markers in basic research and diagnostic assays, must be coated, or capped, with one of a wide variety of organic molecules in order to stabilize these nanocrystals and prevent them from aggregating when added to water.

Once coated, researchers then add a targeting agent, such as an antibody or aptamer, that enables the quantum dot to bind tightly to a biomolecule of interest.

Michael Strano, Ph.D., and colleagues at the University of Illinois have a discovered that they can combine capping and targeting in a simple step, producing water-soluble lead sulfide (PbS) quantum dots that emit bright near-infrared light. The key discovery, described in a paper published in the Journal of the American Chemical Society, was that aptamers – short stretches of synthetic DNA that have many of the binding properties of antibodies – can function as both a capping agent and a targeting agent.

Aptamer-capped quantum dots, which the researchers create at room temperature in open air, remain stable for months and have diameters ranging from 3 to 6 nanometers. Tests with these coated nanocrystals showed that they bind to their targets within one minute and can detect proteins at concentrations as low as 1 nanomolar.

This work is detailed in a paper titled, “Aptamer-capped nanocrystal quantum dots: a new method for label-free protein detection.” An abstract of this paper is available through PubMed. View abstract.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
You might also like... ×
Research examines molecules derived from ticks as potential COVID-19 treatment option